CoChat

Statins inhibit the dimerization of β-secretase via both isoprenoid- and cholesterol-mediated mechanisms

Open access
Parsons, Richard B., Price, Gemma C., Farrant, Joanna K., Subramaniam, Daryl, Adeagbo-Sheikh, Jubril, Austen, Brian M. · 2006 · Biochemical Journal
Cited by 50

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

We have previously reported that protein lipidation in the form of palmitoylation and farnesylation is critical for the production of Aβ (amyloid β-peptide), the dimerization of β-secretase and its trafficking into cholesterol-rich microdomains. As statins influence these lipid modifications in addition to their effects on cholesterol biosynthesis, we have investigated the effects of lovastatin and SIMVA (simvastatin) at a range of concentrations chosen to distinguish different cellular effects on Aβ production and β-secretase structure and its localization in bHEK cells [HEK-293 cells (human embryonic kidney cells) transfected with the Asp-2 gene plus a polyhistidine coding tag] cells. We have compared the changes brought about by statins with those brought about by the palmitoylation inhibitor cerulenin and the farnesyltransferase inhibitor CVFM (Cys-Val-Phe-Met). The statin-mediated reduction in Aβ production correlated with an inhibition of β-secretase dimerization into its more active form at all concentrations of statin investigated. These effects were reversed by the administration of mevalonate, showing that these effects were mediated via 3-hydroxy-3-methylglutaryl-CoA-dependent pathways. At low (1 μM) statin concentrations, reduction in Aβ production and inhibition of β-secretase dimerization were mediated by inhibition of isoprenoid synthesis. At high (>10 μM) concentrations of statins, inhibition of β-secretase palmitoylation occurred, which we demonstrated to be regulated by intracellular cholesterol levels. There was also a concomitant concentration-dependent change in β-secretase subcellular trafficking. Significantly, Aβ release from cells was markedly higher at 50 μM SIMVA than at 1 μM, whereas these concentrations resulted in similar reductions in total Aβ production, suggesting that low-dose statins may be more beneficial than high doses for the therapeutic treatment of Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20060655

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 50

Metadata

Authors
Parsons, R. B., Price, G. C., Farrant, J. K., Subramaniam, D., Adeagbo-Sheikh, J., & Austen, B. M.
Venue
Biochemical Journal
Published
2006-09-27
Volume
399
Issue
2
Pages
205-214
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W1981776895
Cited by
50
References
4
FWCI
3.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statins inhibit the dimerization of β-secretase via both isoprenoid- and cholesterol-mediated mechanisms. https://app.cochat.ai/papers/10.1042/bj20060655
The paper
Parsons, R. B., Price, G. C., Farrant, J. K., Subramaniam, D., Adeagbo-Sheikh, J., & Austen, B. M. (2006). Statins inhibit the dimerization of β-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Biochemical Journal. https://doi.org/10.1042/bj20060655

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.